IFNG and inflammatory bowel disease: The potent in vitro suppression of IFN‐γ by A. suum EVs suggests that they could serve as therapeutics for autoimmune diseases, as dysregulation of IFN‐γ promotes inappropriate inflammation such as that present in IBD (Langer et al., 2019).